SIRION BIOTECH GmbH 21. Januar 2014

Overcoming drawbacks of gene silencing [PDF]

Over the years SIRION Biotech has developed its base technology into an art: in 80% of recent projects SIRION Biotech managed to identify shRNAs with knockdown results of above 90%. Such experience makes it possible to issue warranties with its quotes.

SIRION Biotech GmbH bietet kundenspezifische Engineering- und Fertigungsdienstleistungen für virale Vektoren für die Life-Sciences-Indus... [mehr]